Data / Drug companies / Acetaminophen, aspirin, and caffeine
Acetaminophen, aspirin, and caffeine: 13 companies and 21 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Acetaminophen, aspirin, and caffeine is listed in the FDA National Drug Code Directory by 13 companies, with 21 products in commercial distribution. 0 of the products (0.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; powder, and the newest product started marketing on February 2, 2026.
The request: Get every company that lists acetaminophen, aspirin, and caffeine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 21
- Generic (ANDA) products
- 0 (0.0%)
- Application numbers
- 2
- Routes
- Oral
- Brand names
- Excedrin Migraine, Extra Strength Headache Relief, Goodys Extra Strength, BioElectro Extra Strength Headache Relief, Extra Strength Pain Reliever, Excedrin Extra Strength, Excedrin Migraine, Travel Basix, Excedrin Migraine, CVP Health
- openFDA record search
- api.fda.gov
Companies that list acetaminophen, aspirin, and caffeine
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Lil' Drug Store Products, Inc. | 6 | tablet, film coated | New drug applications (NDA) | November 29, 2022 |
| Medtech Products Inc. | 4 | powder | Over the counter monograph drugs | February 2, 2026 |
| A-S Medication Solutions | 1 | tablet, film coated | New drug applications (NDA) | September 30, 2020 |
| Advanced Rx LLC | 1 | tablet | Over the counter monograph drugs | July 1, 2025 |
| Bi-Mart | 1 | tablet | Over the counter monograph drugs | February 1, 2025 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | tablet, coated | Over the counter monograph drugs | May 1, 2021 |
| Dse Healthcare Solutions, LLC | 1 | tablet, coated | Over the counter monograph drugs | January 15, 2025 |
| Genomma Lab USA | 1 | tablet | Over the counter monograph drugs | December 26, 2025 |
| Haleon US Holdings LLC | 1 | tablet, film coated | New drug applications (NDA) | September 30, 2020 |
| JHK Inc DBA American Safety & First Aid | 1 | capsule, coated | Over the counter monograph drugs | February 2, 2000 |
| Lil' Drug Store Products, Inc. | 1 | tablet | Over the counter monograph drugs | August 25, 2021 |
| Navajo Manufacturing Company Inc. | 1 | tablet, film coated | New drug applications (NDA) | March 13, 2025 |
| Select Consumer Group | 1 | tablet, film coated | New drug applications (NDA) | September 30, 2020 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 10 | 47.6% |
| Tablet | 4 | 19% |
| Powder | 4 | 19% |
| Tablet, coated | 2 | 9.5% |
| Capsule, coated | 1 | 4.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 14 | 66.7% |
| New drug applications (NDA) | 7 | 33.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Central Nervous System Stimulant | 21 |
| Methylxanthine | 21 |
| Nonsteroidal Anti-inflammatory Drug | 21 |
| Platelet Aggregation Inhibitor | 21 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.